11. Closed nuclear-fuel cycle with fast reactors
1.1. "New technology platform: closed nuclear fuel cycle with fast reactors" (NTP).
1.2. NTP Coordinator – Directorate for Scientific and Technical Complex, Rosatom State Nuclear Energy Corporation.
1.3. List of enterprises and organizations involved in the creation of technology platform:
JSC NIKIET;
|
JSC "SSC RIAR";
|
JSC "OKB Gidropress";
|
JSC SPAEP;
|
JSC "VNIINM";
|
JSC TsKBM;
|
FSUE "SSC RF-IPPE";
|
JSC VTI;
|
JSC ENITS;
|
JSC ENIN;
|
MPEI;
|
FSUE CRISM "Prometey";
|
JSC "Afrikantov OKBM";
|
MSZ;
|
IBRAE;
|
SKhK;
|
SverdNIIkhimmash;
|
JSC AKME-engineering;
|
RCC MSU;
|
VNIIEF;
|
VNIITF;
|
MRRC;
|
IAM RAS;
|
MEPhI;
|
VNIPIET;
|
MZP;
|
GKhK;
|
ChMZ;
|
FSUE "SSC RF-ITEF";
|
SSC IHEP;
|
FSUE "SSC RF-TRINITI";
|
JSC VNIIKHT.
|
1.4. Main technology areas to be realized within the framework of the technology platform:
1.4.1. "The development of fast neutron reactors with closed nuclear fuel cycle":
1.4.1.1. "The development of lead-cooled fast reactors";
1.4.1.2. "The development of fast reactors cooled with lead-bismuth";
1.4.1.3. "The development of sodium-cooled fast reactors";
1.4.1.4. "The development of integrated systems of new generation codes for analysis and justification of the safety of advanced nuclear power plants and nuclear fuel cycle".
1.4.2. "Modernization of nuclear power experimental base":
1.4.2.1. "The development of multi-purpose fast neutron research reactor MBIR";
1.4.2.2. "Technical upgrading of 60 MW(t) fast neutron development reactor";
1.4.2.3. "Technical upgrading of the complex of fast critical facilities for modeling of fast reactors and fuel cycles".
1.4.3. "The development of advanced nuclear fuel production technologies":
1.4.3.1. "The development of technologies and creation of the production of mixed oxide fuel for fast neutron reactors";
1.4.3.2. "The development of technology for fabrication of dense fuel for fast neutron reactors";
1.4.3.3. "The development of advanced structural materials for fast- and thermal-neutron reactors".
1.4.4. "The development of materials and technologies of closed nuclear fuel cycle for fast- and thermal-neutron reactors":
1.4.4.1. The construction and commissioning of multifunctional radiochemical research complex;
1.4.4.2. Computational and experimental justification of the conditions for ultimate disposal of radioactive waste and the development of advanced support technologies;
1.4.4.3. The development of pyrochemical technology of dense fuel reprocessing and radioactive waste management technologies for testing of closed nuclear fuel cycle technologies;
1.4.4.4. The development of design documentation for a special-purpose line at a centralized plant of SNF reprocessing from fast- and thermal-neutron reactors including testing and justification of technological solutions applied.
-
Controlled Fusion Technological Platform (CFTP)
-
CFTP has been initiated by the Russian State Corporation on Atomic Energy.
-
Institutes and organizations participating in CFTP development:
Science Research Center “Kurchatov Institute”
State Research Center Troitsk Institute for Innovation and Fusion Research
D.V.Efremov Scientific Research Institute of Electrophysical Apparatus
N.A.Dollezhal Research and Development Institute of Power Engineering
A.A. Bochvar All-Russian Scientific Research Institute for Inorganic
Materials
Federal State Unitary Enterprise “Krasnaya Zvezda”
National Research Nuclear University – Moscow Engineering Physics Institute
Ioffe Physical Technical Institute, Russian Academy of Sciences
Prokhorov General Physics Institute, Russian Academy of Sciences
Keldysh Institute of Applied Mathematics, Russian Academy of Sciences
Budker Institute of Nuclear Physics, Siberian branch of Russian Academy of Sciences
Institute of Applied Physics, Russian Academy of Sciences
Trapeznikov Institute of Control Sciences, Russian Academy of Sciences
Moscow Institute of Physics and Technology, State University
Bauman Moscow State Technical University
Moscow State University Faculty of Computational Mathematics and Cybernetics
-
Basic technological directions of CFTP
-
Development and modernization of tokamak innovative experimental base
-
New plasma diagnostics tools
-
Theoretical foundations of the processes in fusion devices
-
Blanket technologies, including nuclear technologies of controlled fusion, tritium production, etc.
-
IT, models and codes.
-
Plasma control technologies and systems
-
Demo fusion neutron source
-
Hybrid fusion-fission systems
-
First wall and divertor technologies, including lithium technology of capillary-porous structures
-
Development of new materials
-
Physics of HF and SHF heating, neutral injection
-
Technologies of electron-cyclotron systems (gyrotrons, transmission lines, antennas)
-
Education in plasma physics and control fusion
-
Economic sectors to be influenced by CFTP
-
Research and development in plasma physics and controlled nuclear fusion;
- Nuclear technologies, nuclear engineering, nuclear power;
- Power engineering;
- Mechanical engineering
- Technical superconductivity
-
International cooperation
-
International project ITER
-
Russia-Italy international project IGNITOR
-
International cooperation in plasma studies and controlled fusion
-
International education programs
Information about CFTP initiator
Russian State Corporation on Atomic Energy,
www.rosatom.ru
Address: ul.Bol’shaya Ordynka, 24, Moscow, Russian Federation
Contact person: Cherkovets Vladimir Evgen’evich,
Science Research Center of Russian Federation
Troitsk Institute of Innovation and Fusion Research,
Director
Phone: 8(495) 334-53-08
Fax: 8(495) 334-57-76
e-mail: liner@triniti.ru
-
Radiation technologies
1. Name of the technology platform
Radiation technologies.
2. Coordinator of the technology platform
State Atomic Energy Corporation “Rosatom”
“Radiation technologies” Program
Mr. Mikhail Lobanov
Tel.: 8-965-209-4012
e-mail: lobanov.mm@gmail.com
3. Participant list of technology platform
State Atomic Energy Corporation “Rosatom” and associated companies:
-
D. Efremov Research Institute of Electrophysical Instrumentation (NIIEFA), FSUE (St. Petersburg)Institute of High-Energy Physics, State Scientific Center of the Russian Federation (SSC IFVE), FSUE (Protvino, Moscow Region)
-
Izotop Trans-Regional Association, JSC (Moscow)
-
L.Ya. Karpov Physical-Chemical Research Institute (NIFKhI), FSUE (Moscow)
-
NIITFA— Research Institute of Applied Physics and Automation, JSC (Moscow)
-
A.I. Alikhanov Institute of Theoretical and Experimental Physics, State Scientific Center of the Russian Federation (SSC ITEF), FSUE
-
V.G. Khlopin Radium Institute, Research and Production Complex (RPC), FSUE (St. Petersburg)
-
Research Institute of Atomic Reactors, State Scientific Center Of Russian Federation, JSC (Dimitrovgrad-10, Ulianovsk Region)
-
Mayak Production Association (PA Mayak), FSUE (Ozersk, Chelyabinsk Region)
-
N.L. Dukhov All-Russian Research Institute of Automatics (VNIIA), FSUE (Moscow)
Center for Strategic Research “North-West” Foundation
The Ulyanovsk region government
4. Main tasks and results of technology platform construction
The main tasks of technology platform are represented in the table below:
Table 1. Technology platform main tasks
Area
|
Short-term
|
Medium-term
|
Long-term
|
Market development
| -
Minimization of organizational, financial costs through strengthening cooperation inside technological platform.
-
Supply chains quality raising
-
Attracting additional resources for radiological R&D
| -
Creation of competitive products and services, that could be sold on the world market
-
Attraction of private and state investment to the companies working in the radiation technologies field
| -
Achieving sufficient share of the world medical and industrial radiological equipment market
-
Technological platform participants to be included in the global product value adding chains
|
Social security
| -
Providing information about the nuclear medicine methods to the population
| -
National and international nuclear medicine centers creation
-
Substantial upgradу of the medical service quality
| -
Substantial reduction of mortality caused by oncological diseases
|
Scientific and technical development
| -
New radiopharmaceuticals for diagnostics and therapy development
-
Short-living and ultra-short-living radiopharmaceuticals production setup
| -
Development of the new types of linear accelerators
-
R&D of the new diagnostic and therapeutic medical equipment
-
Proton therapy center setup
| -
Creating of the centers for new medicines development, testing and certification
-
Creation of the industrial and technological zones for radiological equipment production Создание индустриально-
|
Technologies
| -
Methods of radiopharmaceutical application for diagnostics and therapy development
-
Development of the engineering design of radiopharmaceuticals production complex
| -
Development of new manufacturing lines for radiopharmaceuticals production
-
Development of new manufacturing lines for linear accelerators production
-
Development of the diagnostic information base
| -
Development and modernization of the diagnostic and therapeutic medical equipment recycling
|
Production
| -
GMP-certified radiopharmaceuticals production setup
-
Cyclotrons and cyclotron complexes production setup
| -
Development and implementation of the new logistics schemes for radiopharmaceuticals distribution expansion
-
Organization of the modular complexes for radiopharmaceuticals production
|
|
Education
| -
Organization refresher courses for medical and technical staff of radiological equipment
| -
Creation of the training centers for specialists in engineering and maintenance of linear accelerators
-
Creation of the training centers for radiologists and medical physicists
| -
Organization of the special educational centers for radiologists in the universities
|
The main results of technology platform operation are represented in the table below:
Table 2. Main results of technology platform operation
Results
|
Level
|
Terms
|
SPECT, SPECT-CT, PET-CT production setup
|
World level of competitiveness
|
5 years
|
Non-destructive testing equipment production setup
|
World level of competitiveness
|
5 years
|
Equipment for radiological therapy (proton therapy, neutron therapy) production setup
|
World level of competitiveness
|
5 years
|
Short-living and ultra-short-living radiopharmaceuticals production setup
|
Elimination of the lag behind the world level
|
3 years
|
Development of new manufacturing lines for radiopharmaceuticals production
|
World level of competitiveness
|
5 years
|
R&D of the new diagnostic and therapeutic medical equipment
|
World level of competitiveness
|
10 years
|
Creation of the training centers for specialists in engineering and maintenance of radiological medical equipment, radiochemists, radiologists and medical physicists
|
Elimination of the lag behind the world level
|
5 years
|
Nuclear medicine centers construction (Dimitrovgrad, Obninsk, Tomsk, etc.), providing technological base for modernization of healthcare agency.
|
Elimination of the lag behind the world level, in long-term prospect - World level of competitiveness
|
5 years
|
5. Markets and sectors of economy that would be influenced by technological platform
-
Medicine (oncological diseases diagnostics and therapy – more than 2.5 mln of potential patients annually).
-
Transport (security arrangements for airports, railway stations and subway).
-
Light and heavy industry (material features changing), food (imported food disinfection).
6. Possible collaboration with international partners
Collaboration with international manufacturers, distributors, R&D specialists and scientists is useful for the development of the technological platform. It is planned to start and carry on negotiations with foreign companies mentioned below:
Table 3. Foreign companies for possible mutual benefit collaboration
Market sector
|
Main players
|
Consolidation level
|
Volume
|
Diagnostic medical equipment
|
GE Medical Systems
Philips
Siemens
Toshiba
IS2 Medical Systems
Mediso Medical Imaging Systems
|
Medium
|
$45 bn
|
Therapeutic medical equipment
|
Varian
IBA
TomoTherapy
Elekta
Siemens
Accuray
|
High
|
Less than $50 bn
|
Isotopes production
|
MDS Nordion
Covidien IRE
NTP
|
High
|
|
Radiopharmaceuticals production
|
Siemens
IBA Molecular
Bracco Diagnostics Inc
GE Healthcare
MDS Nordion
|
Medium
|
$9 bn
|
Security arrangements
|
Smith
Rapiscan Systems
Varian Medical Security & Inspection Products
AS&E
Nuctech
|
High
|
Less than $5.5 bn
|
Non-destructive testing equipment
|
Varian Medical Security & Inspection Products
Nuctech
GE Inspection Tech.
V.J.Technologies
|
Medium
|
Less than $3 bn
|
Source: Bain & Company, Frost & Sullivan.
Share with your friends: |